SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001583648-18-000043
Filing Date
2018-07-31
Accepted
2018-07-31 16:51:27
Documents
4
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a180731pirs1q201810qa.htm 10-Q/A 90157
2 EXHIBIT 10.1 seagencollaborationagreeme.htm EX-10.1 1182512
3 EXHIBIT 31.1 exhibit3111.htm EX-31.1 4628
4 EXHIBIT 31.2 exhibit3121.htm EX-31.2 4560
  Complete submission text file 0001583648-18-000043.txt   1282985
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-37471 | Film No.: 18981763
SIC: 8731 Services-Commercial Physical & Biological Research